Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 2/3 1

Status

Completed 11Unknown 9Recruiting 6Terminated 2

Sponsor Class

OTHER 4OTHER_GOV 1INDUSTRY 1

Study Type

Observational 3Interventional 3

Sponsor

Cancer Type

Gastrointestinal 6

Conditions

Colorectal Neoplasms 882Pancreatic Neoplasms 573Carcinoma, Hepatocellular 543Stomach Neoplasms 513Esophageal Neoplasms 312Rectal Neoplasms 282Colonic Neoplasms 255Breast Neoplasms 204Neoplasms 201Liver Neoplasms 187Lung Neoplasms 175Carcinoma, Non-Small-Cell Lung 175Cholangiocarcinoma 152Ovarian Neoplasms 142Neoplasm Metastasis 137Gastrointestinal Neoplasms 134Esophageal Squamous Cell Carcinoma 130Melanoma 103Prostatic Neoplasms 99Biliary Tract Neoplasms 95Endometrial Neoplasms 83Uterine Cervical Neoplasms 79Head and Neck Neoplasms 72Squamous Cell Carcinoma of Head and Neck 69Carcinoma, Renal Cell 58Sarcoma 55Adenocarcinoma Of Esophagus 54Urinary Bladder Neoplasms 53Anus Neoplasms 52Triple Negative Breast Neoplasms 48

Interventions

camrelizumab 1Tumor Burden 1Radiation 1Pyloromyotomy 1Botulinum Toxins, Type A 1Blood Specimen Collection 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Recruiting × Esophageal Diseases × Gastrointestinal × Clear all
NCT02526095 2026-05-14

FREGAT

University Hospital, Lille

Recruiting
15,000 enrolled
Gastrointestinal

Esophageal Diseases

NCT00260585 2026-04-14

Esophageal Cancer Risk Registry

University of Pittsburgh

Recruiting
7,000 enrolled
Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Neoplasms, Gastroesophageal Reflux, Hernia, Hiatal

NCT04312633 2026-03-20

Clinical Utility of WATS3D: A 5-Year Prospective Study

CDx Diagnostics

Recruiting
90,000 enrolled
Gastrointestinal

Barrett Esophagus, Esophageal Diseases, Gastroesophageal Reflux

NCT06721520 2026-02-25

EMPTY

The Cleveland Clinic

Phase 2/3 Recruiting
170 enrolled
Gastrointestinal

Esophageal Achalasia, Esophageal Diseases, Esophageal Motility Disorders, Gastroparesis

NCT05624099 2023-10-19

Camrelizumab Combined With Chemoradiotherapy in Advanced Esophageal Cancer.

Fujian Cancer Hospital

Phase 2 Recruiting
75 enrolled
Gastrointestinal

Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms

NCT05252078 2022-12-16

ALTER-E005

Jiangxi Provincial Cancer Hospital

Phase 2 Recruiting
30 enrolled
Gastrointestinal

Esophageal Squamous Cell Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, Digestive System Neoplasms, Esophageal Diseases, Esophageal Neoplasms, Gastrointestinal Diseases, Gastrointestinal Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Squamous Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡